14 oktober 2016
14 oktober 2016

New financing triggered by promising preliminary data from ongoing Phase 1/2 study

Do you like it?
Read more
20 september 2016
20 september 2016

Participation in 3PBio Forum technology transfer panel at BIOSPAIN 2016

Do you like it?
Read more
15 september 2016
15 september 2016

Last patient treated in Phase 1/2 trial with T-Guard® in acute GVHD disease

Do you like it?
Read more
Load more